Supply report · October 2026 register copy
Antimalarials in Nigeria: the registration data
Across the 8 antimalarial molecules Ogbogwu tracks, our October 2026 copy of the NAFDAC Greenbook lists 449 active registrations held by 234 companies — plus 251 registrations recorded as no longer active. Every figure on this page is quoted from that dated copy; the register can change after our copy is taken.
- Active registrations
- 449
- Companies
- 234
- New in the last 12 months
- 46
- Renewals due within a year
- 42
Who holds the registrations
The ten companies with the most active antimalarial registrations in our copy. The registrant is the NAFDAC applicant of record — for imported lines this is often the Nigerian distributor, not the factory.
- 1.Emzor Pharmaceutical Industries— 12 active
- 2.Tridem Pharma Nigeria— 11 active
- 3.Greenlife Pharmaceutical— 9 active
- 4.Geneith Pharmaceuticals— 7 active
- 5.Embassy Pharmaceutical and Chemicals— 5 active
- 6.IPCA Pharma Nigeria— 5 active
- 7.BG Pharma & Healthcare— 4 active
- 8.Krishat Pharma Industries— 4 active
- 9.Patbless Pharmaceutical— 4 active
- 10.Sam Pharmaceutical— 4 active
Where the products are made
Maker country as the register records it, across the 449 active registrations.
- India— 290 (65%)
- Nigeria— 92 (20%)
- China— 62 (14%)
- Malaysia— 1 (0%)
- Morocco— 1 (0%)
- Pakistan— 1 (0%)
- South Korea— 1 (0%)
- Viet Nam— 1 (0%)
Dosage forms
- Tablet— 289 active
- Injection— 44 active
- Powder for injection— 30 active
- Solution for injection— 25 active
- Dispersible tablet— 21 active
- Capsule— 20 active
- Caplet— 6 active
- Powder for suspension— 5 active
Newest registrations
The latest antimalarial approvals in our copy — 46 products were registered in the twelve months to October 2026.
42 active registrations carry expiry dates within the next twelve months. A registration expiry means a renewal is due, not that the product disappears — holders routinely renew — but a lapsed number on a pack is worth checking before a large order. See which ones, by month →
The molecules behind these numbers
- Artemether-Lumefantrine — 288 active registrations
- Artesunate — 51 active registrations
- Artemether — 44 active registrations
- Dihydroartemisinin-Piperaquine — 24 active registrations
- Chloroquine — 14 active registrations
- Artesunate-Amodiaquine — 10 active registrations
- Sulfadoxine-Pyrimethamine — 10 active registrations
- Hydroxychloroquine — 1 active registrations
“Antimalarials” on this page means these molecules — the register itself has no therapeutic grouping, so a category page must say exactly what it counted.
The most-supplied presentations
- Artemether 80 mg + Lumefantrine 480 mg tablet — 141 companies
- Artemether 20 mg + Lumefantrine 120 mg tablet — 90 companies
- Artemether 80 mg/mL injection — 40 companies
- Artesunate 60 mg powder for injection — 17 companies
- Artemether 20 mg + Lumefantrine 120 mg dispersible tablet — 14 companies
- Artemether 80 mg + Lumefantrine 480 mg capsule — 12 companies
Manufacturing or exporting antimalarial medicines?
This is the market you'd be entering. See what NAFDAC registration and import into Nigeria require, and talk to us about distribution.
Supply the Nigerian marketOther supply reports
This page quotes the public NAFDAC Greenbook as of our dated copy, across the molecules Ogbogwu tracks in this category. It is a record of registrations, not market-share or sales data, and not an endorsement of any product. Registration status can change; for decisions that matter, confirm on the official Greenbook.